News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Pathology Companies Leica and Omnyx Beef Up Their Access to Digital Pathology Technology

Leica Microsystem acquires Genetix while Omnyx licenses patents from Olympus

More pathology laboratories are acquiring and deploying digital scanners and digital pathology systems. In response to the growing demand for digital pathology solutions, several prominent companies are extending their capabilities in virtual microscope slide technology. Over recent months, an acquisition and a licensing deal provide examples of the intense activity in the digital pathology marketplace.

The acquisition was done by Leica Microsystem, Inc., of Wetzlar, Germany. On March 10th, it announced its acquisition of Genetix, Ltd., based in New Milton, UK. The licensing deal involved Omnyx, LLC, of Pittsburgh, Pennsylvania, in an agreement that gives it access to certain patents held by Olympus Corporation. Both of these transactions occurred in March. Each was motivated by initiating the company’s need to further develop its technologies in support of whole slide imaging (WSI) and digital pathology systems.

(more…)

Convergence of In Vivo Imaging and Digitized Pathology Is Under Way

Three factors are driving the development of imaging systems in pathology. First, the market for digital pathology imaging systems has accelerating momentum as pathology labs acquire and use this technology. Second, the same factors that drove acceptance of digital radiology systems are encouraging wider use of digital pathology solutions. Third, digital imaging systems hold great promise for pathologists, radiologists, oncologists, and other medical professionals seeking to improve the accuracy and timeliness of diagnostics.

“The fields of imaging and informatics in medicine are on the cusp of fusion with the fields of molecular medicine, pathology imaging, and radiology imaging,” said Michael Becich, M.D., Ph.D. “The point at which these three disciplines intersect offers almost unlimited potential for the future of personalized medicine!” Becich is Chairman of the Department of Biomedical Informatics and Professor of Biomedical Informatics, Pathology, Information Sciences and Telecommunications at the University of Pittsburgh. Becich also is one of three course directors for a conference to be held later this month: Advancing Practice, Instruction and Innovation Through Informatics (APIII).

“It’s a very exciting time to be working in these fields,” explained Becich. “Digitized pathology tools are contributing to more accurate diagnoses. They are also shortening the time required to make a diagnosis on what have been particularly difficult cases, and we are improving patient safety as well.”

Dark Daily readers interested in how digitized pathology is developing and its intersection with radiology imaging will find expert sessions on this topic at the upcoming conference: “Advancing Practice, Instruction and Innovation Through Informatics (APIII), scheduled for October 19-23, 2008 at the Marriott City Center in Pittsburgh, Pennsylvania. Of particular interest, conference co-organizer the Association for Pathology Informatics (API) has developed a partnership with the Society of Imaging and Informatics in Medicine to produce a learning track of sessions for radiology informatics professionals.

“The acceptance of digitized pathology imaging systems by pathologists is gaining speed,” observed Becich. “Use of digitized pathology images is already changing the standard of practice in several areas of surgical pathology. Every pathology group should be developing a strategy that addresses digitized pathology systems. Furthermore, the intersection of in vivo imaging and in vitro molecular testing promises to further transform the traditional work practices in pathology.”

Related Information:

;